Intracardiac pump

By installing intracardiac device components with expansion and contraction mechanisms in the heart chamber, combined with fluid storage and control systems, the existing LVAD pumps have been solved, and the collaborative blood pumping of each chamber of the heart is achieved, improving the improvement of the fluid storage and control system. Blood circulation efficiency and quality of life of patients with heart failure.

CN111405914BActive Publication Date: 2024-12-03罗伯特 E 道格拉斯 +1
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
CN201980003916.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-06-26
Filing Date
2019-06-13
Publication Date
2024-12-03
Estimated Expiration
2039-06-13

AI Technical Summary

Technical Problem

The existing left heart assist device (LVAD) has problems such as limited pump support, high surgical risk, and external pipeline connection when treating patients with heart failure, which is difficult to meet the diverse needs of patients with heart failure.

Method used

Design an intracardiac device component to promote blood flow in different heart cycles by inserting into each chamber of the heart by utilizing the expansion and contraction mechanisms, combining fluid storage and control systems to achieve collaborative support for each chamber of the heart, and through The electrode and the prosthetic valve synchronize the heart.

Benefits of technology

The device can effectively support blood pumping in each chamber of the heart, reduce surgical risks, avoid external pipeline connections, and improve blood circulation efficiency and quality of life in patients with heart failure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN111405914B_ABST
    Figure CN111405914B_ABST
Patent Text Reader

Abstract

An intracardiac device component (ICDC) is inserted into one to four chambers of the heart. In the first period, the ICDC in the right and left atria expand while the tricuspid and mitral valves open. The expansion in the right and left atria pushes blood from these atria into their corresponding ventricles. During this period, the ICDC in the right and left ventricles contract, and the pulmonary and aortic valves close. In subsequent periods, the ICDC in the right and left atria contract while the tricuspid and mitral valves close, and the right and left atria fill with blood. The ICDC in the right and left ventricles expands during this period while the pulmonary and aortic valves open. This sequence increases blood flow into the pulmonary arteries and aorta, and helps to compensate for the reduced pumping capacity of patients with heart failure.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] Aspects of the present disclosure relate generally to medicine and more particularly to heart failure. Background Art

[0002] Heart failure is a medical condition in which the heart cannot adequately pump blood to the body's organs. One of the most common causes is a myocardial infarction (also called a heart attack) from coronary artery disease (narrowing of the heart's blood vessels). During a myocardial infarction, part of the heart muscle is lost, and the remaining heart muscle becomes overworked and stretches out over time. The heart becomes enlarged, causing a decrease in its ability to pump blood. Coronary heart disease and myocardial infarction are just some of the many causes of heart failure. Other causes include high blood pressure, heart valve problems, heart muscle problems (e.g., viral myocarditis, amyloidosis, HIV, arrhythmias, sarcoidosis, etc.), and many others.

[0003] If right heart failure is present (due to disease in the right atrium and ventricle), blood may back up into the body's organs and the patient may suffer from leg swelling. If left heart failure is present (due to disease in the left atrium and ventricle), blood may back up into the lungs and the patient may suffer from severe shortness of breath. Eventually, depending on the cause, heart failure may develop (i.e., worsening pump failure), and the disease may be fatal.

[0004] A left ventricular assist device (LVAD) is a battery-powered mechanical pump that is placed via an open-heart surgical procedure to treat patients with advanced heart failure who are awaiting a heart transplant. The LVAD draws blood from the left ventricle and sends it to the aorta, which then sends it to the rest of the body. The LVAD has several limitations. First, the LVAD only works as a pump to support the left ventricle. Therefore, the other heart chambers are not supported. Second, it requires major open-heart surgery, which carries significant risks. Third, it requires a tube that comes out of the patient's skin to connect the internal hardware to the external hardware outside the body. Therefore, there are a number of challenges associated with LVAD maintenance. Given these limitations, there is a need for better methods and devices to support patients with heart failure. Summary of the invention

[0005] All examples, aspects and features mentioned herein may be combined in any technically possible way.

[0006] According to one aspect of the present invention, a method includes inserting an intracardiac device component (such as but not limited to an intracardiac device component for expansion / contraction) into each chamber of the heart. During a first period, the intracardiac device components in the right and left atria will expand while the tricuspid and mitral valves are open. The expansion of the intracardiac device components in the right and left atria will push increased blood flow from these atria into their respective ventricles. During this period, the intracardiac device components in the right and left ventricles will contract, and the pulmonary and aortic valves will close. Conversely, in a subsequent period, the intracardiac device components in the right and left atria will contract while the tricuspid and mitral valves are closed. The intracardiac device components in the right and left atria will expand during this period, and the pulmonary and aortic valves will open. This sequence will increase blood flow into the pulmonary artery and aorta. The intracardiac device components will alternately expand and contract in successive periods according to the heartbeat and operation of their respective chambers. The intracardiac device components will be placed in one to four chambers of the heart.

[0007] Some embodiments include, but are not limited to, the following elements: an intracardiac device component (ICDC); a pressurized fluid bottle that stores fluid and passes the fluid through a tubing system so that the ICDC expands when the fluid is inserted and contracts when the fluid is released; an inlet / outlet tube for the pressurized fluid having a valve that opens / closes to allow air to enter the ICDC or be released; a storage element for the pressurized fluid; a control mechanism that includes, but is not limited to: a tube pressure gauge; a computing system with an algorithm for timing the opening / closing of one or more fluid / air input / output valves based on collected data (e.g., pressure, volume, rate, etc.) during the emptying of blood from one or more chambers (i.e., the ejection phase); a computing system with an algorithm for timing the opening / closing of one or more fluid / air input / output valves based on collected data (e.g., pressure, volume, rate, etc.) during the filling of blood into one or more chambers; and a power source preferably inside the subcutaneous fat of the chest wall (Note: if the system controller and power source are outside the body, these elements can be connected to a local commercial power source via a backup battery). In further embodiments, desired ejection parameters (e.g., stroke volume, ejection fraction, etc.) may be modified by the intracardiac pump by analyzing multiple factors including, but not limited to, the following: valve opening size, opening duration, and heart chamber size.

[0008] Some embodiments include methods of implanting an ICDC and associated tubes, including but not limited to the following: advancing the device into the body near the superior vena cava (SVC) and into the superior vena cava (SVC), then following the SVC into the right atrium (RA); then inserting ICDC set 1 (IS1) through the atrial septum separating the RA and the left atrium (LA) such that one ICDC will be located in the LA, one in the RA, and the ICDC connector is located in the atrial septum; then inserting ICDC set 2 (IS2) through the RA and into the right ventricle (RV), and moving to a position that allows ICDC set 2 to be inserted through the interventricular septum separating the RV and the left ventricle (LV); one ICDC will be located in the RV, one in the LV, and the ICDC connector is located in the interventricular septum. In continued embodiments: the location of the connector tube will include options: between the connectors of IS1 and IS2; between the connector of IS1 and an external (or internal) fluid storage source; and between the connector of IS2 and an external (or internal) fluid storage source.

[0009] Some embodiments include adding one or more electrodes to the aforementioned set of components. The purpose of these electrodes is to stimulate and synchronize heart function in concert with the ICDC components. The stimulation rate of the electrodes can vary depending on the patient's activity level.

[0010] Some embodiments include variations in the locations of system components. Exemplary locations include, but are not limited to, the following: inside the body as a self-contained unit, but with an alternate power source provided; and the ICDC is inside the body, and the connector tubes and wires are inside and outside the body, and the controller, fluid storage element, and power source are outside the body. In further embodiments, if a pressurized gas (e.g., air) is used as a mechanism to expand the ICDC and release the gas when contraction occurs, the pressurized gas cylinder can hold the gas outside the body and be replaced periodically as the stored gas is consumed. If the fluid used as a mechanism to expand / contract the ICDC is a liquid (e.g., a saline solution), the fluid can be stored within the closed system.

[0011] In addition to fluid pressure differentials, some embodiments include mechanisms to cause ICDCs, including but not limited to the following: For a closed system, a magnetized piston within the tubular system can connect the ICDCs for the right atrium (RA) and left atrium (LA) and the ICDCs for the right ventricle (RV) and left ventricle (LV), which will alternate current between the magnets on the tubular system and the permanent magnets on the pistons. The current provided alternates between the magnets on the tubes and in sync with the heartbeat. Thus, the movement of the piston will push fluid into one ICDC and extract fluid from the other ICDC during one time period, and reverse the flow during a subsequent time period.

[0012] In addition to ICDC, some embodiments include mechanisms to increase blood flow out of the LV. This will include, but is not limited to, the following: a piston in a cylindrical tube that is open at one end located within the LV. During the period when blood is entering the LV from the LA, the piston will be close to the bottom of the cylinder. And, during the ejection period, the piston will move forward toward the open end of the cylinder, thereby pushing the blood in the cylinder out, thereby contributing to the amount of blood ejected during this period. Further embodiments may include, but are not limited to, the following: an alternating current flows between a magnet on the proximal end of the cylinder and a permanent magnet on the piston. The current provided alternates between the magnets on the cylinder in sync with the heartbeat. This option will avoid the need for external / internal storage of fluid.

[0013] Some embodiments include methods that work in conjunction with a pacemaker present in the patient. The method includes, but is not limited to, the following: Signals emitted by the pacemaker can be detected by sensors within the system and transmitted to a controller element. The controller will then synchronize the expansion / contraction of the ICDC accordingly. Note that in the absence of a pacemaker, the system controller will provide timing for the period of expansion / contraction of the ICDC.

[0014] Some embodiments include methods that incorporate pressure sensors within an ICDC element. The methods include, but are not limited to, the following: Include a pressure sensor within the ICDC to sense pressure and pressure changes within the chamber. This information will be transmitted to a controller and can be used to trigger expansion or contraction of the ICDC. The pressure data can also be used for diagnostic purposes.

[0015] Some embodiments include methods of working in conjunction with an artificial valve within the heart. The ICDC is associated with the artificial valve to achieve coordinated motion during positioning of the artificial valve. The method includes, but is not limited to, the following: a mechanical connection between the ICDC and the artificial valve; an electrical connection between the ICDC and the artificial valve; and a sensor system within the ICDC for detecting the position of the artificial valve. Note: The ICDC can work in a similar manner with a natural heart valve to achieve synchronized motion.

[0016] Some embodiments include methods of providing two (or more) levels of pressure for an ICDC. Examples of two-level pressure systems include, but are not limited to, the following: The system may have a high pressure element for the LV and a low pressure element for the RA, LA, and RV. Separate tubes transfer the two different pressure levels of fluid from their storage elements (i.e., high pressure and low pressure) to the corresponding ICDC. This will accommodate pressure differences of approximately an order of magnitude between these chambers.

[0017] Some embodiments include methods of controlling the timing of the periods. The duration of the periods can be controlled by a controller element using manual input from the patient. Variables that may affect the timing include, but are not limited to, the following: the patient's activity level, where the time interval between periods decreases corresponding to an increase in activity level; the interval between periods between selected ICDC activations (e.g., two periods on, two periods off).

[0018] Some embodiments include methods for providing a pre-installation planning process. From a "system" perspective, the amount of blood ejected from each chamber should be approximately equal (assuming no shunting). As an example, total blood flow through the body may be limited due to low ejection of the LV, while the RA, RV, and LA may be able to increase blood flow. In this example scenario, the LV is the "rate limiting step" for flow to the entire body. Based on this rule, the pre-installation process may include, but is not limited to, the following parameters: Pre-existing ejection parameters (such as end-diastolic volume, end-systolic volume, ejection fraction, etc.) can be calculated during an echocardiogram (or other imaging process) when examining the operation of the heart. Based on the size of the chambers, the current level of ejection volume in each chamber, and the desired ejection level, the size of the ICDC can be calculated to achieve the desired extraction level compared to the current level of ejection. This in turn will determine the size of the ICDC and the fluid flow rate into the ICDC.

[0019] Some embodiments include methods of providing a check on the operation of the system. This would include, but is not limited to, the following: The system may include an ultrasonic monitor that would perform the function of performing an echo calculation of the ejection volume for each chamber after installation and during operation of the system. The monitor may be connected to the system controller and, if necessary, may calculate the ICDC size adjustments for each chamber and the control system will perform these required adjustments.

[0020] Some embodiments include methods that provide within the system controller the ability to generate a report regarding the utilization of the system during a reporting period. Reporting elements may include, but are not limited to, the following: The report may: indicate the ICDC size for each chamber during each period: relevant ejection parameters for each chamber for each period (e.g., end-systolic volume, end-diastolic volume, ejection fraction, etc.); and the number of periods; total ejection volume during the reporting period; and statistics regarding these tests. If pressure readings within the chambers are available, these readings may be included in the report. This information may be related to the patient's health and the progress of indicators such as athletic performance. As the patient's overall health improves, device parameters (e.g., ICDC size) for each period of health status may be adjusted. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 The flow of oxygenated blood into the left ventricle with the assistance of intracardiac device components is shown.

[0022] Figure 2 Operation of components of an intracardiac device during ventricular ejection is shown.

[0023] Figure 3 Operation of components of an intracardiac device during atrial ejection is shown.

[0024] Figure 4 An embodiment of an intracardiac pump system component is shown.

[0025] Figure 5 The intracardiac device component (ICDC) sub-element is shown.

[0026] Figure 6 Intracardiac device component volumes and internal pressures during expansion / contraction phases are shown.

[0027] Figure 7 Intracardiac device component requirements are shown.

[0028] Figure 8 The overall intracardiac pump system components are shown.

[0029] Fig. 9 An overview of the clinical setting, device placement, and follow-up period is shown.

[0030] Fig.10 An overview of a preferred method of placing an ICDC is shown.

[0031] Fig.11 The corresponding pressures in the heart and arteries during expansion and contraction are shown.

[0032] Fig.12 A system is shown where some of the fluid moves back and forth from the atrial component of the ICDC to the ventricular component of the ICDC.

[0033] Fig.13 An ICDC system with the addition of electrodes for stimulating cardiac operation and a prosthetic valve is shown.

[0034] Fig.14 A device is shown that can be placed through the interventricular septum with a single puncture and allow intracardiac pump access to each atrium and each ventricle.

[0035] Fig.15 An embodiment is shown in which the interventricular septum can be penetrated with a single puncture and the ICDC can be passed into each atrium and each ventricle.

[0036] Fig.16 An exemplary ICDC device is shown, wherein when the ICDC expands, the pressure inside the device decreases.

[0037] Fig.17The ICDC volume displacement and internal pressure during the expansion / contraction phases were quantified.

[0038] Fig.18 A simplified system is shown that includes only the left ventricular ICDC and no reservoir. DETAILED DESCRIPTION

[0039] Figure 1 Oxygenated blood is shown flowing into the left ventricle 208 during contraction of the left atrium 206, with the mitral valve 222 opening, thereby allowing oxygenated blood 226 to flow into the left ventricle 208, which expands during this portion of the cycle. The aortic valve 224 is now closed. The intracardiac device, including the atrial component 102 and the ventricular component 104, facilitates the flow of oxygenated blood 226 through volume displacement. As the left atrium 206 empties / contracts, the atrial intracardiac device component (ICDC) 102 within the left atrium 206 expands (increases in volume). As the left ventricle 208 fills / relaxes, the ventricular ICDC 104 contracts (decreases in volume). During the next portion of the cycle, the expansion / contraction process is reversed, i.e., the left atrium 206 expands and the left ventricle 208 contracts. In this next portion of the cycle, the aortic valve 224 will then be opened, thereby allowing oxygenated blood 226 to flow to the body, and the mitral valve 222 will be closed. The right atrium and right ventricle undergo similar expansion / contraction using their respective valves. Thus, the ICDC supports the heart during both the filling and emptying phases by displacing blood volume through expansion / contraction.

[0040] Figure 2 The operation of the ICDC 102, 104 during ventricular ejection is shown. The ventricular ICDC 104 expands as the right ventricle 204 and the left ventricle 208 empty / contract. The ventricular ICDC 104 expands in the right ventricle 204, pushing deoxygenated blood 228 through the pulmonary valve 220 into the pulmonary artery 214. At the same time, the ventricular ICDC 104 pushes oxygenated blood 226 from the left ventricle 208 through the aortic valve 224 into the aorta 212. The tricuspid valve 218 is closed. The mitral valve 222 is also closed. During this period, the atrial ICDC 102 shrinks, which helps deoxygenated blood 228 flow from the inferior vena cava and superior vena cava 210 into the diastolic right atrium 202, while oxygenated blood 226 flows from the pulmonary veins 216 into the diastolic left atrium 206. Not all chambers in the heart are the same size and shape, so each ICDC can be specifically designed for a chamber that has a specific volume shift due to expansion and contraction, for example.

[0041] Figure 3 ICDC operation during atrial ejection is shown. This cardiac operation period follows Figure 2. The atrial ICDC 102 expands as the right atrium 202 and the left atrium 208 empty. The ventricular ICDC 104 contracts as the right ventricle 204 and the left ventricle 208 fill. Each ICDC may be comprised of different materials, shapes, and sizes. For ease of illustration, an atrial ICDC 102 having a balloon-type design is shown, and a ventricular ICDC 104 having a piston-cylinder-type design is shown. The tricuspid valve 218 opens, allowing deoxygenated blood 228 to flow from the right atrium 202 to the right ventricle 204. The pulmonary valve 220 is closed. The mitral valve 222 opens, allowing oxygenated blood 226 to flow from the left atrium 206 to the left ventricle 208. The pulmonary valve 220 and the aortic valve 224 are closed during this period.

[0042] Figure 4 An embodiment of a piston-cylinder type ICDC 100 is described in more detail. A battery pack 400 provides power to the system. A computer / control system 402, which may be a programmable device either intracardiac or external (e.g., subcutaneous chest wall), provides timing for the ICDC 100. These computer / control system 402 commands may be transmitted to the ICDC via an electrical connection 404 or via a wireless system. A fluid storage device 406 (e.g., compressed air, incompressible fluid) is shown on the right side of the figure. The fluid flows from the storage device to the ICDC 100 via a tube 408 (i.e., made of a non-flexible material). A penetrator device 410 is also shown, which is designed to penetrate (i.e., create a small hole) in the atrial or ventricular septum for device placement. Variations on the layout of the system include whether the key components are inside or outside the body. Note that the ICDC 100 has a plurality of components that will be described below. Figure 7 The multiple sub-elements described in the invention include: a housing sub-element, an internal support structure, a volume expansion / contraction sub-element, an internal medium sub-element, a heart fixation sub-element, a sensor component, and a control component.

[0043] Figure 5The subcomponents of the balloon design ICDC are described in more detail. The tube for fluid 408 (e.g., compressed air) to pass through the subcomponents of the ICDC that passes through the atrial septum or the ventricular septum. Two balloons 500 are connected by the subcomponent 502 of the ICDC attached to the atrial septum or the ventricular septum. The balloon subcomponents 500 of the ICDC expand and contract to replace blood to assist the heart to pump. These balloons 500 are located in the left atrium and the right atrium, or the left ventricle and the right ventricle, or in both. As shown, although two balloons 500 are shown, the expansion / contraction subcomponents may include but are not limited to a cylinder with an internal piston or similar device, which will allow expansion to push blood out of the chamber or allow contraction to allow blood to flow into the chamber. The balloon 500 volume expansion / contraction subcomponents in the right atrium / ventricle surround the internal medium subcomponents. The ICDC can be sent or received via electrical connection 404 or wireless communication. The subcomponents of the ICDC 100 will pass through the wall (atrial septum or ventricular septum) separating each chamber. The heart fixation sub-element 502 is on the atrial or ventricular septum. The housing sub-element surrounds the internal support structure and houses the sensor components and control components.

[0044] Figure 6 The volume displacement and internal pressure of the ICDC 100 during the expansion / contraction phase are quantified. Specifically, the volume and pressure within the ICDC are shown as a function of expansion (i.e., expansion) and contraction (i.e., contraction). The volumes and pressures shown are exemplary only and will vary depending on the patient.

[0045] Figure 7ICDC functions and requirements are shown. Although the figure is self-explanatory, it is important to note the flexibility of the design. For example, a variety of non-toxic materials can be used for ICDC. Similarly, different mechanisms can be used to replace a certain volume of blood by expansion / contraction or decompression / compression. ICDC has multiple sub-elements, including: shell sub-element 700, internal medium sub-element 702, volume expansion / reduction sub-element 704, internal support structure sub-element 706, and heart fixation sub-element 708. Shell sub-element 700 has specific design requirements 710. Because the shell material contacts the heart and blood, it should meet a series of strict requirements, including but not limited to the following requirements: durability, air tightness, liquid tightness, non-toxicity, and smooth edges. Materials may include but are not limited to the following: metal, non-metal, plastic, synthetic, autograft, and allograft. Internal medium sub-element 702 can have specific design requirements 712. The internal medium is nominally composed of a compressible gas that allows the volume of the ICDC to increase / decrease, or an incompressible fluid with a reservoir located outside the ventricle. The volume expansion / reduction subelement 704 has specific design requirements 714. The volume expansion / reduction subelement is performed synchronously with the emptying / filling of the heart chamber. Materials may include, but are not limited to: balloons, springs, pistons, etc. The internal support structure subelement 706 may have specific design requirements 716. The internal support structure subelement provides the following: fixation of the volume expansion / reduction subelement to the heart fixation subelement, housing the sensor subelement, and housing the control subelement. The heart fixation subelement 708 has specific design requirements 718. The heart fixation subelement provides attachment of the heart device to the heart (e.g., the fibrous portion of the ventricular septum).

[0046] Figure 8The entire system components are shown. The entire system 800 has multiple elements: an intracardiac device component 100, a control device 804, a battery pack 806, a penetrator device 808, a communication system 810, a hose 812, and (if applicable) one or more heart valves 814. The ICDC 100 function 816 is to perform continuous cycles of deflation and expansion 816. The control device 804 (e.g., an electrical device in the subcutaneous fat of the chest wall) function 818 is to control ICDC parameters (e.g., rate and volume of expansion / contraction, etc.) based on heart rhythm monitoring. The battery pack 806 (e.g., including batteries in the housing of the device in the subcutaneous fat of the chest wall) function 806 is to power both the electrical device in the chest wall and the ICDC 820. The battery pack can be included in the same housing as the electrical device in the chest wall, or separated for easier replacement. The penetrator device 808 function 822 is to penetrate the atrial septum or the ventricular septum. The penetrator device 808 can be made of various materials (e.g., metal or non-metal), shapes (e.g., with varying sharpness), etc. The penetrator device 808 can be used only once, when the ICDC is placed. The communication system 810 function 824 is to provide power and information transmission between the elements of the intracardiac pump overall system. Note that a wireless communication system 810 can also be implemented. The hose sub-element 812 has the function 826 of performing the transmission of gas or other fluid to allow the ICDC to expand or contract. Note that during the expansion phase of the ICDC, the gas or fluid can be transmitted from the outside to the heart and then to the inside of the heart. Alternatively, the gas or fluid can be transmitted from an ICDC component in one chamber to an ICDC component in another chamber. The hose 812 can be made of, including but not limited to, non-flexible materials (including plastics, rubber, In addition, the heart valve(s) 814 may be integrated into the overall system so that the ICDC 100 works in conjunction with the heart valve 814 function 828 of opening and closing the cycle.

[0047] Fig. 9An overview of the clinical setting, placement of the device, and a follow-up period is shown. The figure illustrates in context the process by which the patient will be treated. It is important to plan in advance regarding the internal placement of the ICDC. It should also be noted that there is considerable flexibility in the number of expansion / contraction devices placed in the heart, which can range from one chamber to all four chambers. It should also be noted that the timing and volume expansion / contraction are clinically reviewed and adjusted as needed for a period of time immediately following the placement of the intracardiac device components. The first step 900 is to perform a preoperative assessment, including patient history (e.g., shortness of breath), physical examination (e.g., jugular venous distension), laboratory evaluation (e.g., important cardiac markers), preoperative imaging (e.g., echocardiogram), and diagnosis (e.g., left heart failure with an ejection fraction of 20%). Accurately characterize the rhythm and precise timing of contraction of the right atrium, left atrium, right ventricle, and left ventricle. The second step 902 is to select specific intracardiac device components (e.g., univentricular vs. biventricular vs. atrioventricular combination; volume capacity, material, etc.) and Figure 8 The third step 904 is to conduct a preoperative planning meeting(s) (e.g., determine if it is an endovascular or open procedure, key anatomical landmarks to note, etc.). The fourth step 906 is to place the ICDC and accessories. In addition, the staff will also perform initial monitoring, adjust the device (or replace it as clinically indicated), etc. The fifth and final step 908 is to perform routine follow-up, where the device is adjusted or replaced as clinically indicated.

[0048] Fig.10An overview of a method for placing an ICDC intravascularly through the venous side is shown, wherein the preferred venous access site is the jugular vein. The first step 1000 is jugular vein acupuncture, dilation of the tract, cutting of the vessel if necessary, and placement of a large sheath into the jugular vein and then into the superior vena cava. There are multiple paths through which one or more intracardiac device expansion / contraction components can be placed into the heart. Optionally, this can be placed through femoral vein access. The second step 1002 is to pass the ICDC with associated wires / tubes through the sheath, through the superior vena cava, through the right atrium, and then into the right ventricle. The third step 1004 is to form a small hole through the fibrous portion of the ventricular septum using a penetrator device under image guidance, thereby creating a small ventricular septal defect. Then, a cardiac fixation device is placed to fix the ICDC to the fibrous portion of the ventricular septum and allow internal fluid media to be transmitted between the ICDC components in the right ventricle and the ICDC components in the left ventricle. The fourth step 1006 is used to place the left ventricular component of the ICDC into the left ventricle through the newly created ventricular septal defect, and the right ventricular component of the ICDC into the right ventricle. The fifth step 1008 is used to fix the device in the appropriate position of the heart in a way that seals the created ventricular septal defect. The sixth step 1010 is to place the wire so that the wire penetrates the right ventricle, right atrium, superior vena cava and jugular vein from the ICDC and is connected to the electrical control device in the chest wall. The electrical activity of the heart is monitored, and the ICDC begins to pump in a synchronized mode to assist the heart and improve the ejection fraction to an optimal level. After the device is placed, the operator will evaluate, modify if necessary, and perform a standard vein / skin suture process.

[0049] Fig.11The corresponding pressures of the heart and arteries during expansion and contraction are shown. The guide wire 404 is shown as entering the right atrium 202 from the superior vena cava, passing through the tricuspid valve 204 and reaching the ICDC device 100 located at the fibrous portion of the interventricular septum, and the balloon component 500 is located in the right ventricle 204 and the left ventricle 208. A table illustrating the target pressure in the heart chamber and leaving the artery is also shown. Note that the pressure difference between the left ventricle (LV) / aorta and other chambers in the heart is close to an order of magnitude. This higher pressure is obtained by the strong muscle structure of the left ventricle 208. It should also be noted that when a patient suffers from a myocardial infarction, some of this muscle tissue may be damaged, resulting in a decrease in cardiac output. This reduction is compensated by the expansion / contraction element 500 of the ICDC 100. This can help the left ventricle to recover function over time. The volume of the expansion / compression element 500 located in the left ventricle 208 and the right ventricle 204 can be the same or slightly different according to the doctor's needs. This shows that the specific size of these elements will be determined based on the specific heart structure and disease of the patient at hand. An alternative arrangement would be to have a single fluid storage source 1100 located in the right atrium 202. Another alternative arrangement would be to have a fluid storage source 1100 located in the right atrium and a fluid storage source located in the left atrium 1102. The fluid storage sources could be secured to the atria by a securing device 1104. This arrangement would allow intravascular placement of all structures connected in a single device since all structures are connected in a linear fashion.

[0050] Fig.12The system is shown in which some of the fluid is moved back and forth from the atrium ICDC 102 to the ventricle ICDC 104. The illustration is during a period when the left ventricle 208 ejects oxygenated blood 226 into the aorta 212. The right atrium displacement subcomponent 102a of the ICDC 102 is contracted (illustrated as moving from a large dashed ellipse to a smaller solid ellipse), which helps to draw deoxygenated blood 228 from the superior / inferior vena cava 210 into the right atrium 202. The left atrium displacement subcomponent 102b of the ICDC 102 is contracted (illustrated as moving from a large dashed ellipse to a smaller solid ellipse), which helps to draw oxygenated blood 226 from the pulmonary veins 216 into the left atrium 206. The right ventricle displacement subcomponent 104a of the ICDC 104 is expanded (illustrated as moving from a dashed ellipse to a larger solid ellipse), which helps the right ventricle 204 eject deoxygenated blood 228 through the open pulmonary valve 220 into the pulmonary artery 214. Note that the tricuspid valve 218 is closed during this period. The left ventricular displacement subcomponent 104b of the ICDC 104 expands (illustrated as moving from a dotted ellipse to a larger solid ellipse), which helps the left ventricle 208 eject oxygenated blood 226 through the open aortic valve 224 into the aorta 212. Note that the mitral valve 222 is closed during this period. As the atrial displacement component of the ICDC 102 shrinks, the fluid medium moves from the atrial displacement component of the ICDC to the hose 1200. The location of the hose 1200 can be varied (e.g., by any combination of the right atrium 202, the right ventricle 204, the left atrium 206, the left ventricle 208, the valve, or the myocardium). The wire 404 that connects the ICDC to the rest of the device is also shown. Note that the balloon size, shape, material, and other properties can be varied so that it is optimally designed for the heart chamber in which it is placed. The period shown in the figure has blood filling the atrium and blood flowing out of the ventricle. This particular configuration stores fluid within the intracardiac device expansion / contraction components as shown and eliminates the need for a fluid storage device (e.g., storage outside the heart, such as within the pleural cavity) and the tubing associated with the fluid storage device. The sub-element within the cylinder connecting the intracardiac device expansion / contraction components within the atria and those within the ventricles may have a piston (or other type of sub-element) that draws fluid from the atrial intracardiac device expansion / contraction components and pushes fluid into the ventricular intracardiac device expansion / contraction components. This process will be reversed during subsequent cardiac operation periods.

[0051] Fig.13The ICDC system is shown with electrodes and a prosthetic valve added to stimulate heart function. The illustration is during a period when the left ventricle 208 ejects oxygenated blood 226 into the aorta 212. The right atrium displacement subcomponent 102a of the ICDC 102 is contracted (illustrated as moving from a large dashed ellipse to a smaller solid ellipse), which helps draw deoxygenated blood 228 from the superior / inferior vena cava 210 into the right atrium 202. The left atrium displacement subcomponent 102b of the ICDC 102 is contracted (illustrated as moving from a large dashed ellipse to a smaller solid ellipse), which helps draw oxygenated blood 226 from the pulmonary vein 216 into the left atrium 206. The right ventricle displacement subcomponent 104a of the ICDC 104 is expanded (illustrated as moving from a dashed ellipse to a larger solid ellipse), which helps the right ventricle 204 eject deoxygenated blood 228 through the open pulmonary valve into the pulmonary artery 214. Note that the tricuspid valve 218 is closed during this period. The left ventricular displacement subcomponent 104b of the ICDC 104 expands (illustrated as moving from a dotted ellipse to a larger solid ellipse), which helps the left ventricle 208 eject oxygenated blood 226 through the open aortic valve 224 into the aorta 212. Note that the mitral valve 222 is closed during this period. As the atrial displacement component of the ICDC 102 shrinks, the fluid medium moves from the atrial displacement component of the ICDC to the hose 1200. The location of the hose 1200 can be varied (e.g., by any combination of the right atrium 202, the right ventricle 204, the left atrium 206, the left ventricle 208, the valve or the myocardium). The wire 404 connecting the ICDC to the rest of the device is also shown. A possible design alternative is to incorporate electrodes to stimulate the operation of the heart. The electrodes and associated electrical connection wires 1300 that transmit electrical pulses are shown in red and can be used to stimulate the right atrium 202, the left atrium 206, the right ventricle 204, the left ventricle 208, or any combination thereof. A control unit (not shown) will determine the timing of the emitted electrical pulses. These pulses will in turn indicate the contraction / relaxation of the chamber with the corresponding valve opening / closing. It should also be noted that an artificial valve or other device can also be incorporated into the overall device. For example, an example of a mechanical mitral valve 1302 is shown.

[0052] Fig.14An embodiment is shown in which an ICDC can be placed intravascularly and access each atrium and each ventricle by a single puncture through the interventricular septum. An electrical control device 402 and a battery 400 are connected to the ICDC via a wire 404. The wire 404 is attached to the right atrium ICDC fluid storage device 1100, which is shown as having a fastening device 1104 so that it can be fastened to the right atrium. Both the wire 404 and the fluid delivery tube 408 extend from the right atrium ICDC fluid storage device 1100 to the right ventricle ICDC device 500. The fixation device 100 that has been placed through the interventricular septum connects the right ventricle ICDC device 500 to the left ventricle ICDC device 500. The fixation device 100 includes the wire 404 and optionally includes a tube. The guide wire 404 and tube 408 extend from the left ventricle ICDC device 500 to the reservoir 1100 in the left atrium, where the reservoir 1100 can be attached to the left atrium via a fixation device 1104. Near the end of the tube, a penetrator device 410 can be included so that the device can be placed through the ventricular septum. Alternatively, the penetrator device 410 can be a separate device.

[0053] Fig.15 An embodiment is shown in which the ICDC can be passed through the interventricular septum by a single puncture and enter each atrium and each ventricle. The electrical control device 402 and the battery 400 are connected to the ICDC via a wire 404. The wire 404 is attached to the right atrium ICDC fluid storage device 1100, and the right atrium ICDC fluid storage device 1100 is shown as having a fastening device 1104 so that it can be fastened to the right atrium. The wire 404 extends from the right atrium ICDC fluid storage device 1100 to the right ventricle ICDC device 500. The fixture 100 that has been placed through the interventricular septum connects the right ventricle ICDC device 500 to the left ventricle ICDC device 500. The fixture 100 includes a wire 404. The wire 404 extends from the left ventricle ICDC device 500 to the reservoir in the left atrium. Near the end of the tube, a penetrator device 410 may be included so that the device can be placed through the interventricular septum. Alternatively, the penetrating device 410 may be a separate device. Note that there is no tube in this device. Thus a ductless system can be achieved.

[0054] Fig.16 An exemplary ICDC device is shown, where the pressure inside the device decreases when the ICDC expands. This can be achieved by an air and device filled balloon 1600 with a mechanical volume displacement device that includes a hub 1602 and spoke 1606 device that uses pistons to change the radius of the device and drive the expansion and contraction of the device. Fig.16A shows the deflation of the balloon 1600, where the radius of the spokes 1606 decreases. During this period, the pressure inside the balloon increases, while the pressure inside the ventricle decreases, which helps the ventricle fill. Fig.16 B shows the balloon 1600 being expanded by increasing the radius of the spokes 1606. During this period, the pressure inside the balloon drops and the pressure inside the ventricles increases, helping the ventricles to empty. The central hub of the ICDC will have pistons on the spokes that will protrude radially outward in a spherical shape. The tips of the spokes 1600 will contact the surface of the balloon 1600 and will be designed to be round and durable.

[0055] Fig.17 The volume displacement and internal pressure of the ICDC during the expansion / contraction phases are quantified. In this example, the difference in the volume of the ICDC from the expansion phase (34mL of volume) to the contraction phase (4mL of volume) is approximately 30mL. The volume of compressible material (i.e., air) within the material is 33mL in the expansion phase and 3mL in the contraction phase. The volume of incompressible material within the ICDC is shown as 1mL in both the expansion and contraction phases. The standard pressure-volume relationship will be used for calculations. This shows that the ICDC pressure will be lower in the expansion phase and higher in the contraction phase. This system using air will not require multiple fluid storage devices.

[0056] Fig.18 A simplified system is shown that includes only the left ventricular ICDC and no reservoir. This can be placed through a single puncture through the interventricular septum and provide a single ICDC in the left ventricle. The electrical control device 402 and battery 400 are connected to the ICDC via wires 404. A portion of the ICDC 502 is used to secure the device to the right ventricular side of the interventricular septum, which is connected to another portion of the ICDC 100 that passes through the interventricular septum and connects to the left ventricular ICDC balloon device 500, which is located in the left ventricle. Fig.16 . The fixation device 100 includes a guide wire 404. The guide wire 404 extends into the left ventricle ICDC device 500 to a reservoir in the left atrium. A penetrator device 410 may be included so that the device can be placed through the ventricular septum. Alternatively, the penetrator device 410 may be a separate device. Note that neither the tube nor the reservoir are present in the device, which highlights the flexibility of the system.

Claims

1. An intracardiac pump system comprising a first intracardiac device component and a second intracardiac device component; The first intracardiac device component comprises: An expandable and contractible left atrium displacement subcomponent located in the left atrium; an expandable and contractible right atrium displacement subcomponent located in the right atrium; and a first cardiac fixation device, which connects the left atrium displacement subcomponent and the right atrium displacement subcomponent through the atrial septum of the left atrium and the right atrium and allows fluid medium to be transferred between the left atrium displacement subcomponent and the right atrium displacement subcomponent; wherein the first intracardiac device component is configured such that, while the tricuspid valve and the mitral valve of the heart are opened, the left atrium displacement subcomponent and the right atrium displacement subcomponent expand in volume to transfer blood from the left atrium and the right atrium to the left ventricle and the right ventricle; and while the tricuspid valve and the mitral valve of the heart are closed, the left atrium displacement subcomponent and the right atrium displacement subcomponent contract in volume; The second intracardiac device component comprises: an expandable and contractible left ventricular displacement subcomponent located in the left ventricle; an expandable and contractible right ventricular displacement subcomponent located in the right ventricle; and a second cardiac fixation device, which connects the left ventricular displacement subcomponent and the right ventricular displacement subcomponent through the interventricular septum of the left ventricle and the right ventricle and allows fluid medium to be transferred between the left ventricular displacement subcomponent and the right ventricular displacement subcomponent; wherein the second intracardiac device component is configured such that, while the pulmonary valve and the aortic valve of the heart are closed, the volumes of the left ventricular displacement subcomponent and the right ventricular displacement subcomponent contract; and, while the pulmonary valve and the aortic valve of the heart are opened, the volumes of the left ventricular displacement subcomponent and the right ventricular displacement subcomponent expand; The intracardiac pump system further includes a connecting tube connecting the first intracardiac device component and the second intracardiac device component to allow fluid media to be transferred between the first intracardiac device component and the second intracardiac device component.

2. The system of claim 1, wherein the first and second intracardiac device components are configured to repeat volume expansion and volume contraction in successive periods in response to timing of the heart.

3. The system of claim 1, wherein the first intracardiac device component and the second intracardiac device component are configured to repeat volume expansion and volume contraction in successive periods in synchronization with electrical pulses delivered to a wall of a chamber of the heart through electrodes.

4. The system of claim 1, comprising a controller, the first intracardiac device component and the second intracardiac device component being configured to vary the timing of volume expansion and volume contraction over successive periods in response to input from the controller.

5. The system of claim 1, the first intracardiac device component and the second intracardiac device component configured to vary the timing of volume expansion and volume contraction over successive periods in response to a patient activity level.

6. The system of claim 1, wherein the first intracardiac device component and the second intracardiac device component are configured to iterate volume expansion and contraction over a continuous period of time in synchronization with a signal from a pacemaker.

7. The system of claim 6, wherein the first intracardiac device component and the second intracardiac device component are configured to desynchronize volume expansion and contraction using a signal emitted by the pacemaker in response to a severe arrhythmia.

8. According to the system of claim 1, a first expansion volume of the first intracardiac device component and a second expansion volume of the second intracardiac device component are determined by calculation, and the first expansion volume and the second expansion volume are calculated based on a pre-existing blood ejection fraction of each chamber, a size of each chamber, and at least one of a desired output.

9. The system of claim 8, the first intracardiac device component being configured to the calculated first expansion volume.

10. The system of claim 8, the first expansion volume being adjusted based on echocardiographic data.

11. The system of claim 8, comprising a storage module for storing data indicating at least one of a calculated first expansion volume, a calculated second expansion volume, a relative volume of blood ejected from each chamber per period, a number of periods, a total volume of blood pumped, and a pressure in each chamber.

12. The system of claim 1, further comprising electrodes secured to a wall of a chamber of the heart to deliver electrical pulses to synchronize the heart with the first and second intracardiac device components.

13. The system of claim 1, wherein the second intracardiac device component generates a greater expansion pressure in the left ventricle than in the right atrium, the left atrium, and the right ventricle.

14. The system of claim 1, further comprising a power source positioned in the chest wall.

15. The system according to claim 1, Also includes: a compressible material filling the first and second intracardiac device components that decreases in pressure and / or increases in pressure when the first and second intracardiac device components expand and / or contract in volume; as well as A controller actuates the left atrial displacement subcomponent, the right atrial displacement subcomponent, the left ventricle displacement subcomponent, and the right ventricle displacement subcomponent to control repetition of volume expansion and contraction thereof.

16. The system of claim 15, wherein: The compressible material is a gas.

Citation Information

Patent Citations

  • Congenital heart disease sends pulmonary hypertension circulation model

    CN207517243U

  • Heart assisting device

    JP1998174713A

  • How to replace a heart valve using a flexible tube

    KR1019990076885A

  • A device and a method to controllably assist movement of a mitral valve

    SE1050283A1

  • Methods and apparatus for reducing localized circulatory system pressure

    US20020173742A1